The National COVID‐19 Clinical Evidence Taskforce: pregnancy and perinatal guidelines
DescriptionThrough continual surveillance of the available evidence, the National COVID‐19 Clinical Evidence Taskforce identifies, evaluates and synthesises new research to ensure the evidence that underpins the guideline recommendations is up to date. Consequently, the Taskforce recommendations are updated regularly, as new evidence emerges.
The Taskforce guidance for pregnant and breastfeeding women includes recommendations on the approach to care for women with COVID‐19, including mode of birth, delayed cord clamping, breastfeeding, skin‐to‐skin contact after birth and rooming‐in. These areas were prioritised at the outset owing to concerns about caring for women with COVID‐19 and the consequences of high levels of restrictive practice, and they are revisited regularly.
The pregnancy and perinatal guidelines produced by the National COVID‐19 Clinical Evidence Taskforce are an essential resource for doctors who provide acute and primary maternity care services.
This MJA guideline summary shares more.
Learning Outcomes
- Explain key components of the guideline.
- List main recommendations.
- Recognise changes in management as a result of the guideline.
Authors: Caroline SE Homer, Vijay Roach, Leila Cusack, Michelle L Giles, Clare Whitehead, Wendy Burton, Teena Downton, Glenda Gleeson, Adrienne Gordon, Karen Hose, Jenny Hunt, Jackie Kitschke, Nolan McDonnell, Philippa Middleton, Jeremy JN Oats, Antonia W Shand, Kellie Wilton, Joshua Vogel, Julian Elliott, Steven McGloughlin, Steve J McDonald, Heath White, Saskia Cheyne and Tari Turner, for the National COVID‐19 Clinical Evidence Taskforce
Article Type: Guideline summary
Provided by
